Uric Acid - Key Ingredient in the Recipe for Cardiorenal Metabolic Syndrome
Мочевая кислота — ключевой ингредиент в развитии кардиоренального метаболического синдрома
2013-01-01
SCID: 54.1/wnah3z5k
Discuss with AI
cardiorenal metabolic syndromedietary fructoseinsulin resistanceserum uric aciduric acid-lowering therapy
Figures from the paper
Abstract (AI)
Elevated serum uric acid levels are a frequent finding in persons with obesity, hypertension, cardiovascular and kidney disease as well as in those with the cardiorenal metabolic syndrome (CRS). The increased consumption of a fructose-rich Western diet has contributed to the increasing incidence of the CRS, obesity and diabetes especially in industrialized populations. There is also increasing evidence that supports a causal role of high dietary fructose driving elevations in uric acid in association with the CRS. Animal and epidemiological studies support the notion that elevated serum uric acid levels play an important role in promoting insulin resistance and hypertension and suggest potential pathophysiological mechanisms that contribute to the development of the CRS and associated cardiovascular disease and chronic kidney disease. To this point, elevated serum levels of uric acid appear to contribute to impaired nitric oxide production/endothelial dysfunction, increased vascular stiffness, inappropriate activation of the renin-angiotensin-aldosterone system, enhanced oxidative stress, and maladaptive immune and inflammatory responses. These abnormalities, in turn, promote vascular, cardiac and renal fibrosis as well as associated functional abnormalities. Small clinical trials have suggested that uric acid-lowering therapies may be beneficial in such patients; however, a consensus on the treatment of asymptomatic hyperuricemia is lacking. Larger randomized controlled trials need to be performed in order to critically evaluate the beneficial effect of lowering serum uric acid in patients with the CRS and those with diabetes and/or hypertension.
Key Findings
1
Elevated serum uric acid is frequently associated with obesity, hypertension, cardiovascular disease, kidney disease, and cardiorenal metabolic syndrome.
2
Evidence from animal and epidemiological studies supports a potential causal role for fructose-rich diets in raising uric acid and promoting cardiorenal metabolic syndrome.
3
High uric acid may promote insulin resistance and hypertension through endothelial dysfunction, vascular stiffness, renin-angiotensin-aldosterone system activation, oxidative stress, and maladaptive inflammation.
4
Small clinical trials suggest uric acid-lowering therapy could benefit affected patients, but treatment of asymptomatic hyperuricemia remains unresolved and requires larger randomized controlled trials.
5
These uric-acid-associated abnormalities may drive vascular, cardiac, and renal fibrosis and related functional impairment.
Research Object
Cardiorenal metabolic syndrome associated with elevated serum uric acid and fructose-rich dietary exposure
Research Subject
The pathophysiological role of elevated serum uric acid in promoting insulin resistance, hypertension, vascular, cardiac, and renal dysfunction and fibrosis
Publication Details
Publication Date
2013-01-01
Journal
Publisher
ISSN
Cited by
241
Open access PDF
Access Type
Author Information
Download PDF
Subscribe to digest